Literature DB >> 24359784

The identification and pharmacokinetic studies of metabolites of salvianolic acid B after intravenous administration in rats.

Qu Qi1, Kun Hao1, Fei-Yan Li1, Li-Juan Cao1, Guang-Ji Wang1, Hai-Ping Hao2.   

Abstract

AIM: To identify and quantify the major metabolites of salvianolic acid B (SAB) after intravenous injection in rats.
METHODS: LC-IT/TOF-MS was used to identify the metabolites in rat bile, plasma, and urine; LC-MS/MS was used to quantify the two major metabolites.
RESULTS: In rat bile, plasma, and urine, nine metabolites were identified, including methylated metabolites of SAB, lithospermic acid (LSA), the decarboxylation and methylation metabolites of LSA, salvianolic acid S (SAS), and dehydrated-SAS. The t1/2 of monomethyl-SAB and LSA were both very short, and monomethyl-SAB had a larger AUC than LSA in rats.
CONCLUSION: Nine metabolites were found, the metabolic pathway was described, and the pharmacokinetic profiles of LSA and monomethyl-SAB were studied, thereby clarifying that methylation was the dominant metabolic pathway for SAB in rats.
Copyright © 2013 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Identification; Metabolites; Pharmacokinetics; Salvianolic acid B

Mesh:

Substances:

Year:  2013        PMID: 24359784     DOI: 10.1016/S1875-5364(13)60101-6

Source DB:  PubMed          Journal:  Chin J Nat Med        ISSN: 1875-5364


  5 in total

Review 1.  Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors.

Authors:  Khaled S Abdelkawy; Kelsey Lack; Fawzy Elbarbry
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

Review 2.  Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage.

Authors:  Zhun Xiao; Wei Liu; Yong-Ping Mu; Hua Zhang; Xiao-Ning Wang; Chang-Qing Zhao; Jia-Mei Chen; Ping Liu
Journal:  Front Pharmacol       Date:  2020-11-11       Impact factor: 5.810

3.  Erythrocyte Membrane-Enveloped Salvianolic Acid B Nanoparticles Attenuate Cerebral Ischemia-Reperfusion Injury.

Authors:  Shanshan Zhang; Ruoqi Li; Yingyi Zheng; Yuan Zhou; Xiang Fan
Journal:  Int J Nanomedicine       Date:  2022-08-10

Review 4.  Possible applications of salvianolic acid B against different cancers.

Authors:  Iram Shahzadi; Zain Ali; Sidra Bukhari; Acharan S Narula; Bushra Mirza; Reza Mohammadinejad
Journal:  Explor Target Antitumor Ther       Date:  2020-08-31

5.  Validated LC--MS/MS method for determination of YH-8, a novel PKnB inhibitor, in rat plasma and its application to pharmacokinetic study.

Authors:  Qianqian Zhai; Jing Pang; Guoqing Li; Congran Li; Xinyi Yang; Liyan Yu; Yucheng Wang; Jian Li; Xuefu You
Journal:  Acta Pharm Sin B       Date:  2015-05-28       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.